Aktionsplan Biomind Labs Inc.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen Biomind Labs Inc.
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. weitere details| Industry | Biotechnology |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Дивиденд ао | 0.3737 |
| Сайт | https://www.biomindlabs.com |
| Цена ао | 0.7 |
| Preisänderung pro Tag: | 0% (0.7) |
|---|---|
| Preisänderung pro Woche: | 0% (0.7) |
| Preisänderung pro Monat: | 0% (0.7) |
| Preisänderung über 3 Monate: | 0% (0.7) |
| Preisänderung über sechs Monate: | +165.25% (0.2639) |
| Preisänderung pro Jahr: | +536.36% (0.11) |
| Preisänderung über 3 Jahre: | -10.14% (0.779) |
| Preisänderung seit Jahresbeginn: | +127.57% (0.3076) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Mr. Alejandro Antalich | CEO & Director | 1974 (51 Jahr) | |
| Mr. Oscar Alejandro Leon | CFO & Director | 1960 (65 Jahre) | |
| Ms. Paola Diaz Dellavalle Ph.D. | Chief Scientific Officer | ||
| Mr. Juan Presa | Chief Legal Officer | ||
| Ms. Magdalena Alvarez M.A. | Head of Communication | ||
| Mr. Martin Daners | Head of Quality Assurance & Regulatory Affairs |
Adresse: Uruguay, Canelones, Building Ceibo Of. 002 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.biomindlabs.com
Webseite: https://www.biomindlabs.com
